Sonnet BioTherapeutics (SONN) Projected to Post Earnings on Tuesday
Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.92) per share for the quarter. Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) last issued its quarterly earnings results on Thursday, February […]
